Esben Jannik Bjerrum

Esben Jannik Bjerrum wants to battle diseases by inventing novel medicines. To accomplish this, he develops AI and ML-based methods and applies them to drug discovery projects. He obtained a PhD in computational chemistry from the Danish University of Pharmaceutical Sciences in 2008. He has since worked in the interface between IT, drug discovery, and research, both in industry, as a postdoc, and as an independent consultant. Over the years, he has gotten increasingly involved in machine learning and lastly artificial neural networks and deep learning for chemical applications. He joined AstraZeneca in late 2018.